FDA Engagement and Approval Confidence

Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

See omnystudio.com/listener for privacy information.